Suppression of lipopolysaccharide-induced upregulation of toll-like receptor 4 by emodin in mouse proximal tubular epithelial cells

Mol Med Rep. 2012 Sep;6(3):493-500. doi: 10.3892/mmr.2012.960. Epub 2012 Jun 21.

Abstract

The aim of this study was to investigate the effects of emodin, the major component of Rheum palmatum, on lipopolysaccharide (LPS)-induced toll-like receptor 4 (TLR4) expression in cultured mouse tubular epithelial cells (TECs). The TECs were obtained from mice and incubated with LPS and/or indicated concentrations of emodin for 24 h. Cytokeratin, α-SMA and vimentin were detected using immunohistochemistry. The TLR4 protein level was detected by flow cytometry. TNFα and IL-6 protein levels were measured using an enzyme-linked immunosorbent assay (ELISA). mRNA expression of TLR4, TNFα and IL-6 was detected using a reverse-transcription polymerase chain reaction (RT-PCR). Results showed that a concentration of 102 ng/ml LPS significantly upregulated TLR4 mRNA and protein levels. TNFα and IL-6 mRNA and protein levels were also increased. Emodin (at doses of 40, 20 and 10 µM) was able to inhibit LPS-induced TLR4 protein synthesis in cultured TECs. However, TNFα and IL-6 protein expression was decreased in cells treated with emodin at concentrations of 40 and 20 µM. These results demonstrate that an elevated expression of inflammatory cytokines and TLR4 in cells stimulated with LPS, were simultaneously inhibited by emodin. Emodin is therefore able to inhibit the LPS-induced expression of TLR4 in order to downregulate TNFα and IL-6 synthesis in TECs, which may contribute to the protective effects of emodin in renal disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Emodin / pharmacology*
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Immunohistochemistry
  • Interleukin-6 / genetics
  • Interleukin-6 / metabolism
  • Kidney Tubules, Proximal / cytology
  • Lipopolysaccharides / toxicity
  • Male
  • Mice
  • Protein Kinase Inhibitors / pharmacology*
  • Rheum / chemistry
  • Toll-Like Receptor 4 / genetics
  • Toll-Like Receptor 4 / metabolism*
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism
  • Up-Regulation / drug effects

Substances

  • Interleukin-6
  • Lipopolysaccharides
  • Protein Kinase Inhibitors
  • Toll-Like Receptor 4
  • Tumor Necrosis Factor-alpha
  • Emodin